Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

PaQ device improves glycemia control in patients with diabetes

Feb. 26, 2015

Saroglitazar reverses biochemical manifestations of metabolic syndrome

Feb. 25, 2015

New orexin receptor antagonists disclosed by Merck & Co.

Feb. 25, 2015

Xeris Pharmaceuticals presents comparative PK/PD study of G-Pump and GlucaGen

Feb. 25, 2015

ZP-GA-1 shows similar PK characteristics to native glucagon

Feb. 25, 2015

Arrowhead begins phase I trial of ARC-AAT

Feb. 24, 2015

New softgel capsule technology provides better patient experience

Feb. 24, 2015

Study tests effects of alprostadil cream on genital blood flow

Feb. 24, 2015

Novo Nordisk reports positive results from phase II trial of oral semaglutide in type 2 diabetes

Feb. 23, 2015

New SHIP-2 inhibitors for diabetes designed by University of Toyama

Feb. 23, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...